申请人:Gruenenthal GmbH
公开号:US20130231327A1
公开(公告)日:2013-09-05
Substituted spiro-amide compounds corresponding to formula I
in which R
5
through R
8
, D, X, Y and Z have defined meanings, processes for preparing such spiro-amide compounds, pharmaceutical compositions containing such compounds, and methods of using such spiro-amide compounds for treating and/or inhibiting disorders or disease states mediated at least in part by the bradykinin 1 receptor.
本发明提供了对应于式I的取代螺环酰胺化合物,其中R5至R8、D、X、Y和Z具有定义的含义,制备这种螺环酰胺化合物的过程,含有这种化合物的药物组合物以及使用这种螺环酰胺化合物治疗和/或抑制至少部分由激肽酶1受体介导的疾病或疾病状态的方法。